NCT06223464

Brief Summary

This study aims to evaluate the potential of cervical elastography, a non-invasive method, in the accurate diagnosis and clinical course of adenomyosis. Cervical elastography is an imaging method that measures the elasticity properties of cervical tissue using ultrasound technology. This method may be helpful in providing information about the development and clinical course of adenomyosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 18, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2023

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 13, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 25, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 18, 2024

Completed
Last Updated

January 25, 2024

Status Verified

January 1, 2024

Enrollment Period

2 months

First QC Date

January 13, 2024

Last Update Submit

January 23, 2024

Conditions

Keywords

adenomyosiselastographycervical

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of Adenomyosis

    MUSA Criteria

    2 months

Secondary Outcomes (1)

  • Diagnosis of Adenomyosis-Cervical Elastography

    4 months

Study Arms (2)

Adenomyosis-Case Group

The study will include those diagnosed with adenomyosis who were evaluated by gynecological examination and ultrasonographic imaging after the application to Etlik City Hospital Gynecology and Obstetrics Clinic, aged 18-45 reproductive period, pregnancy status excluded, without cervical infection, pathology and anomaly, without systemic disease findings and diagnoses, without chronic drug use.

Healthy patients-Control

The study will include those who have been gynecologically examined and evaluated with ultrasonographic imaging after the application to Etlik City Hospital Gynecology and Obstetrics Clinic, aged 18-45 reproductive period, pregnancy status excluded, without cervical infection, pathology and anomaly, without systemic disease findings and diagnoses, without chronic drug use, without adenomyosis diagnosis.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

The study will be included in our study as two case groups with and without the diagnosis of adenomyosis, whose age is 18-45 reproductive period, pregnancy status is excluded, without cervical infection, pathology and anomaly, without systemic disease findings and diagnoses, without chronic drug use, whose gynecological examination was performed and evaluated by ultrasonographic imaging after the application to Etlik City Hospital Gynecology and Obstetrics Clinic. MUSA criteria will be used in the diagnosis of adenomyosis and elastography measurements in kPa will be performed similar to the studies in the literature examples section in the file.

You may qualify if:

  • Female patients between 18-45 years of age who volunteered and consented to the reproductive period study
  • Patients diagnosed with adenomyosis using MUSA criteria

You may not qualify if:

  • Pregnancy status
  • Pelvic/Cervical infection, pathology and anomalies
  • History of cervical surgery
  • Diagnosis and findings of systemic disease
  • Chronic drug use
  • Advanced maternal obesity preventing measurement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, 06000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Adenomyosis

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist Doctor

Study Record Dates

First Submitted

January 13, 2024

First Posted

January 25, 2024

Study Start

October 18, 2023

Primary Completion

December 18, 2023

Study Completion

April 18, 2024

Last Updated

January 25, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Patient data is not open to access due to hospital policy. however, the principal investigator can be reached via e-mail if necessary

Locations